Helmut Brunar
Chairman of the Board
Biopharma
Axentis Pharma
Switzerland
Biography
Helmut Brunar developed his passion for biopharma as early as 1995 at Sandoz biologics. He later established his footprint in the industry as project manager at Kwizda Pharma, where he led the development of filgratism Biosimilar (marketed today as GRASTOFIL in EU and canada). He managed manufacturing innovation projects, implemented quality systems, and guided through health authority inspections. He has high level competences in clinical trials and regulatory pathways pre- and Post- approval. Helmut is a frequently invited lecturer at biopharma conferences and a regular panellist on discussions on how to overcome market entry challenges.
Research Interest
Biopharma
